These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28740538)

  • 21. Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway.
    Liu Y; Xu W; Zhai T; You J; Chen Y
    Acta Pharm Sin B; 2019 Jul; 9(4):745-757. PubMed ID: 31384535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo effects of ethanol extract combined with Curcumae Radix and Glycyrrhizae Radix et Rhizoma on menopausal metabolic disturbances.
    Park I; Ryuk J; Lee H; Go H; Ko B
    Int J Clin Exp Med; 2015; 8(9):15076-86. PubMed ID: 26628991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic Natural Killer T-cell and CD8+ T-cell Signatures in Mice with Nonalcoholic Steatohepatitis.
    Bhattacharjee J; Kirby M; Softic S; Miles L; Salazar-Gonzalez RM; Shivakumar P; Kohli R
    Hepatol Commun; 2017 Jun; 1(4):299-310. PubMed ID: 29152605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preventive and therapeutic effects of compound ginkgo extract in rats with nonalcoholic steatohepatitis induced by high-fat, high-fructose diet].
    Yang Q; Zhao H; Zhou AZ; Lou ZH
    Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):852-858. PubMed ID: 27978932
    [No Abstract]   [Full Text] [Related]  

  • 25. CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis.
    Rahman SM; Schroeder-Gloeckler JM; Janssen RC; Jiang H; Qadri I; Maclean KN; Friedman JE
    Hepatology; 2007 May; 45(5):1108-17. PubMed ID: 17464987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel inhibitor of stearoyl-CoA desaturase-1 attenuates hepatic lipid accumulation, liver injury and inflammation in model of nonalcoholic steatohepatitis.
    Kurikawa N; Takagi T; Wakimoto S; Uto Y; Terashima H; Kono K; Ogata T; Ohsumi J
    Biol Pharm Bull; 2013; 36(2):259-67. PubMed ID: 23370355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ganoderic acid A ameliorates non-alcoholic streatohepatitis (NASH) induced by high-fat high-cholesterol diet in mice.
    Zhu J; Ding J; Li S; Jin J
    Exp Ther Med; 2022 Apr; 23(4):308. PubMed ID: 35340879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-apoptotic and anti-inflammatory effects of Silybum marianum in treatment of experimental steatohepatitis.
    Aghazadeh S; Amini R; Yazdanparast R; Ghaffari SH
    Exp Toxicol Pathol; 2011 Sep; 63(6):569-74. PubMed ID: 20471811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hepatoprotective effect of the combination use of Fructus Schisandrae with statin--A preclinical evaluation.
    Wat E; Ng CF; Wong EC; Koon CM; Lau CP; Cheung DW; Fung KP; Lau CB; Leung PC
    J Ethnopharmacol; 2016 Feb; 178():104-14. PubMed ID: 26666731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis.
    Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Krag A; Karsdal MA; Nielsen MJ; Brockbank S; Cruwys S
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G410-G418. PubMed ID: 31905026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sivelestat alleviates nonalcoholic steatohepatitis in mice through inhibiting activation of Kupffer cells].
    Zang SF; Ma XJ; Wang L; Zhu GL; Yang WJ; Liu YL; Yan J; Luo Y; Zhuang ZJ; Chen JY; Xun YH; Shi JP
    Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):371-376. PubMed ID: 28763845
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of Hugan Qingzhi tablets on AMPK pathway activation and NF-κB-p65 protein expression in the liver of rats with nonalcoholic fatty liver disease].
    Yao XR; Xia F; Tang WJ; Zhou BJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Jan; 37(1):56-62. PubMed ID: 28109099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
    Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
    Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet.
    Jeong MJ; Kim SR; Jung UJ
    Nutr Res; 2019 Apr; 64():64-71. PubMed ID: 30802724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intervention of Catalpol on High-fat Diet Induced Nonalcoholic Fatty Liver Disease in Mice].
    Tian X; Xiong Q; Chen L; Wen JR; Ru Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):746-755. PubMed ID: 31907123
    [No Abstract]   [Full Text] [Related]  

  • 37. Metabolic response of soy pinitol on lipid-lowering, antioxidant and hepatoprotective action in hamsters fed-high fat and high cholesterol diet.
    Choi MS; Lee MK; Jung UJ; Kim HJ; Do GM; Park YB; Jeon SM
    Mol Nutr Food Res; 2009 Jun; 53(6):751-9. PubMed ID: 19205001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genistein can ameliorate hepatic inflammatory reaction in nonalcoholic steatohepatitis rats.
    Yin Y; Liu H; Zheng Z; Lu R; Jiang Z
    Biomed Pharmacother; 2019 Mar; 111():1290-1296. PubMed ID: 30841442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice.
    Nakano S; Katsuno K; Isaji M; Nagasawa T; Buehrer B; Walker S; Wilkison WO; Cheatham B
    J Clin Exp Hepatol; 2015 Sep; 5(3):190-8. PubMed ID: 26628836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic Effect of Gypenosides on Nonalcoholic Steatohepatitis via Regulating Hepatic Lipogenesis and Fatty Acid Oxidation.
    Li H; Ying H; Hu A; Hu Y; Li D
    Biol Pharm Bull; 2017; 40(5):650-657. PubMed ID: 28458350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.